Priscila Goes Camargo

13PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 08, 2026
Synergistic Cytotoxicity of Cafestol and Kahweol With Doxorubicin in Breast Cancer Cells Involves TNF‑α Targeting and NF‑κB Downregulation.

|Jan 26, 2026
Machine Learning and Molecular Modeling for Drug Repurposing Targeting Potential PI3Kα Inhibitors in Post-CoViD-19 Pulmonary Fibrosis.

Carine Ribeiro Dos Santos, Priscila Goes Camargo, Carlos Rangel Rodrigues

|Jul 20, 2025
Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies.

Raiane Dandara Pereira Pimentel, Priscila Goes Camargo, Pedro Henrique R de A Azevedo

|Feb 19, 2025
In silico evaluation of N-aryl-1,10-phenanthroline-2-amines as potential inhibitors of T. cruzi GP63 zinc-metalloprotease by docking and molecular dynamics simulations.

Priscila Goes Camargo, Ramon Borges da Silva, Aline Araujo Zuma

|May 21, 2024
Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.

Priscila Goes Camargo, Carine Ribeiro Dos Santos, Magaly Girão Albuquerque

|Apr 14, 2024
Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro.

Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Larissa Esteves Carvalho Constant

Pageof 3

Frequent Collaborators

10 joint publications

Camilo Henrique S Lima

8 joint publications

Marcelle L F Bispo

4 joint publications

Kaio Maciel de Santiago-Silva

4 joint publications

Magaly Girão Albuquerque